PEMJECT


500 mg lyophilised powder for solution for infusion (50 ml vial)
scheduling status
S4
registration number
51/26/1066
What PEMJECT contains
Each vial contains pemetrexed disodium hemipentahydrate equivalent to 500 mg pemetrexed. When reconstituted, PEMJECT solution contains 25 mg/mL pemetrexed.
other ingredients
Contains sugar (mannitol, 500 mg). Hydrochloric acid and sodium hydroxide (for pH-adjustment).
Therapeutic classification
L01BA04: Folic acid analogues. A 26: Cytostatic agents.
© 2026 SAHPRA. ALL RIGHTS RESERVED